In an analysis of histologically heterogeneous BCC patient samples, CAIX was highly expressed in more aggressive types (~60%) of BCC compared to low-risk types (~10%) and was associated with poor relapse-free survival. Here, CA9 is linked to skin basal cell carcinoma.